Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Analysis in British Columbia, Canada.
Mohammad AtiquzzamanPeter BirksMicheli U BevilacquaMichelle M Y WongYuyan ZhengOgnjenka DjurdjevAdeera LevinPublished in: Canadian journal of kidney health and disease (2022)
In British Columbia, only 1 in 4 CKD patients with cHK were dispensed with SPS/CPS, mostly with higher degrees of hyperkalemia. These medications appeared to be moderately effective in reducing the serum potassium concentration. Future research is necessary to evaluate the comparative effectiveness of newer generation medications.